Colder Weather May Bring Added Discomfort For Raynaud's Sufferers PDF Print E-mail
Tuesday, 17 November 2009 14:02
taken from http://www.flickr.com/photos/denisecarbonell/3269836335/ via creative commonsColder weather triggers a painful and sometimes debilitating disorder for many who suffer from Raynaud's disease. Raynaud's is an autoimmune disorder in which spasms in the blood vessels can interrupt blood flow to the fingers, toes, nose and ears. Exposure to cold triggers the spasms, typically causing the affected area to turn white, then blue, then bright red. Emotional stress can also cause an attack.

During an attack, Raynaud's sufferers experience tingling, swelling or painful throbbing. Episodes may last from minutes to hours. In severe cases, the area may develop ulcerations and infections.

According to the Raynaud's Association, only one out of five sufferers seeks treatment. Both men and women suffer from Raynaud's, but women are nine times more likely to be affected. "Some researchers estimate as many as 20 percent of all women in their childbearing years have Raynaud's," says Lynn Wunderman, chair of the Raynaud's Association.

"Too many Raynaud's sufferers dismiss their symptoms as being due to 'poor circulation,'" Wunderman says. "In a sense that's true, but there's a medical cause for their poor circulation -- and sometimes it can be serious."

In some cases, Raynaud's symptoms may indicate a serious underlying disorder such as Scleroderma, lupus or rheumatoid arthritis. Robert Riggs, CEO of the Scleroderma Foundation, notes that more than 90 percent of people diagnosed with systemic scleroderma also have Raynaud's. "In most of these cases, Raynaud's is the first symptom."

These patients are considered to have "secondary Raynaud's," meaning another associated disease is present. Fortunately, however, most Raynaud's sufferers have the more benign "primary" form. The Raynaud's Association and the Scleroderma Foundation advise individuals with symptoms to consult with their physicians, who can perform simple blood tests to determine whether or not antibodies associated with other diseases are present. Rheumatologists -- physicians who specialize in the diagnosis and treatment of arthritis, Raynaud's and diseases of the joints, muscles and bones -- may be consulted.

At this time there is no cure for Raynaud's, although research is underway. In the meantime, sufferers are advised to avoid cold temperatures as much as possible, effect lifestyle changes and protect the affected extremities with gloves, hats and other such measures. "Obviously, winter presents the biggest challenges," says Wunderman. So, should Raynaud's sufferers move south for the winter? "Well," she concludes, "that might help somewhat, if you can avoid all of those frigid air conditioned places -- not an option for many sufferers in their daily lives."

This article was taken in part from the PR Newswire. For a link to the orginal  article, click here. To find out more about Raynaud's, click here for our previous article, and do visit the Raynaud's Association for more... and do remember to stay warm.
 
More articles :

» Quality Indicator Sets For Scleroderma

Despite the increasing awareness of Scleroderma (SSc), it continues to have a detrimental effect of the quality of health and lives of those with it. The medical community has recognized that although early treatment of can have a substantial...

» A Scleroderma Fact Sheet

Below, is a very useful fact sheet on Scleroderma. Making for much easier reading and reference, this fact sheet highlights what Scleroderma is, how is it diagnosed, who gets it, complications which may arise, and how it can be treated. Feel free to...

» Caution Needed When Using ACE Inhibitors in Scleroderma

Exposure to angiotensin-converting enzyme inhibitors prior to the onset of renal crisis in patients with increases the risk of death, according to 1-year findings from the prospective observational International Scleroderma Renal Crisis Survey.The...

» Active Biotech Presents Data regarding the 57-57 Project at EULAR

Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data from an exploratory clinical trial in Systemic Lupus Erythematosus (SLE) patients at the Annual European Congress of Rheumatology EULAR 2011, an international event for specialists in the...

» Health: It's About Changing Your State Of Mind

I read an interesting article by Jason Luban, a licensed acupuncturist, on why so many patients flock to alternative practitioners. Mr. Luban brought up an interesting question, “What is health?”Is health simply the absence of disease?  If...

» An Approach to the Treatment of Scleroderma

Systemic sclerosis is unique among the rheumatic diseases because it presents the challenge of managing a chronic multisystem autoimmune disease with a widespread obliterative vasculopathy of small arteries that is associated with varying degrees of...